A Study to Assess Efficacy of an Experimental Oral Rinse in Providing Long Term Relief From Dentinal Hypersensitivity

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 7, 2017

Primary Completion Date

October 27, 2017

Study Completion Date

October 27, 2017

Conditions

Dentin Sensitivity

Interventions

DEVICE

Potassium oxalate

Oral rinse containing 1.5 percent (%) KOX and 0 ppm fluoride

DRUG

Sodium fluoride

Oral rinse containing 0.02% weight by weight (w/w) sodium fluoride (NaF)

OTHER

Placebo

Oral rinse containing 0% KOX and 0 ppm fluoride

Trial Locations (1)

GSK Investigational Site, Fort Wayne